Our researchers have developed commercialisation opportunities in a range of fields, including new medical treatments, diagnostic assays, and a game to aid physiotherapy and rehabilitation.
We're looking for commercial partners to take these opportunities to market.
Explore opportunities below.
A screening service available from ARU can identify anti-fibrotic activity of novel small molecules and biologicals.
We have a suite of PCR assays available for licensing. They're robust, specific, simple and sensitive assays to identify a range of common fungal and antibiotic-resistant infections.
Work with us on a cost-effective rehabilitation game that improves the range of motion and the kinematic ability of motor-impaired participants. Use for physiotherapy purposes at home or in community settings.
Our researchers have identified a potential new treatment for cancer. We're seeking a commercial partner to develop the use of sucralose as a cancer treatment.
We've identified a potential new treatment for fibrotic diseases using two generic compounds, giving the potential for a new combination therapy.
Contact our Research and Innovation Development Office to discuss these opportunities.